Skip to main content
Caplight Logo









Amplifold

Amplifold

Private
GermanyHealthcare & Life Scienceshttps://amplifold.com/

Last Round

Seed

Dec 10, 2025

Total Funding Raised

$5.82M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Amplifold is a biotechnology company that develops a DNA-origami-based signal amplification platform to enhance the sensitivity of lateral flow assays.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

molecular diagnosticsin vitro diagnosticsIVDDNA origamisignal amplificationdiagnostic hardwareassay reagentslateral flowbiotech platformclinical testingnanotechnologydiagnostic techlab techbiotech R&Ddeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplifold Comparables

Compare Amplifold with similar companies based on industry and business-model similarity.

Amplifold comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Detechgene
75%
Torus Biosystems
73%
Danaher Corporation
72%

Amplifold Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 10, 2025

Amplifold Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Dr Federico Bürsgens to join as CEO, effective July 1st, 2026.

  • May 15, 2026

    Monthly visitors increased 215% MoM.

Amplifold Filings

Explore SEC and related filing metadata, where available.

Amplifold filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amplifold's valuation, stock price, and market status.

Is Amplifold a public or private company?

Amplifold is a private company.

What is the current stock price of Amplifold?

Amplifold is a private company with no public stock price. No recent secondary market data is available.

How much is Amplifold worth (valuation)?

Valuation information for Amplifold is not publicly available.

Can I buy Amplifold stock?

Amplifold shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amplifold's last funding round?

Amplifold's most recent funding round was Seed on December 10, 2025.

Who are the main investors in Amplifold?

Key investors in Amplifold include xista science ventures, Matterwave Ventures.

Will Amplifold IPO soon?

No public IPO plans have been announced for Amplifold.

How can I track Amplifold secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplifold's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGermany
Employee Range9
Year Founded2025
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?